Literature DB >> 3311684

Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents.

M Murray1.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3311684     DOI： 10.3109/03602538708998300

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  11 in total

1.  Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4.

Authors:  S Kanamitsu; K Ito; C E Green; C A Tyson; N Shimada; Y Sugiyama
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Structural features of some diphenhydramine analogues that determine the interaction with rat liver cytochrome P-450.

Authors:  E Rekka; H Timmermann; A Bast
Journal:  Agents Actions       Date:  1989-04

3.  The xenobiotic inhibitor profile of cytochrome P4502C8.

Authors:  C E Ong; S Coulter; D J Birkett; C R Bhasker; J O Miners
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

4.  Antipyrine metabolism is not affected by terbinafine, a new antifungal agent.

Authors:  R Seyffer; M Eichelbaum; J C Jensen; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.

Authors:  A M Ndifor; R E Howells; P G Bray; J L Ngu; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450.

Authors:  F S LaBella; G Queen; G Glavin; G Durant; D Stein; L J Brandes
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

7.  Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics of praziquantel in rats.

Authors:  C M Masimirembwa; Y S Naik; J A Hasler
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jul-Sep       Impact factor: 2.441

8.  Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

Authors:  D Sesardic; A R Boobis; B P Murray; S Murray; J Segura; R de la Torre; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

9.  Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6.

Authors:  C M Masimirembwa; J A Hasler; I Johansson
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 10.  Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies.

Authors:  M Teresa Donato; José V Castell
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 5.577
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.